merged_adhd-life-expectancy.txt
<question_number>1</question_number>
<answer>The British study estimated life expectancy using all-cause mortality data, while the 2022 JAMA Pediatrics meta-analysis focused on unnatural deaths, making direct comparison of mortality risk magnitudes misleading.</answer>

<question_number>2</question_number>
<answer>Without knowing specific causes of death, preventive strategies cannot effectively target the most relevant risks, such as suicidality or poor health behaviors, beyond the identified comorbidities.</answer>

<question_number>3</question_number>
<answer>The British study highlights a significant reduction in life expectancy, whereas Barkley's analogy implies that proper lifelong management could mitigate such risks, potentially conflicting with observed mortality patterns.</answer>

<question_number>4</question_number>
<answer>The study notes A.D.H.D. is underdiagnosed, yet rising diagnoses in marginalized groups suggest increasing recognition, which could complicate conclusions about its true mortality impact.</answer>

<question_number>5</question_number>
<answer>N/A</answer>